title: Efficient activation of Valpha14 invariant NKT cells by foreign lipid antigen is associated with concurrent dendritic cell-specific self recognition.
abstract: A burst release of cytokines by Valpha14 invariant NKT (iNKT) cells upon their TCR engagement critically regulates innate and adaptive immune responses. However, it remains unclear in vivo why iNKT cells respond efficiently to microbial or intracellular lipid Ags that are at low levels or that possess suboptimal antigenicity. We found that dendritic cells (DCs) potentiated iNKT cells to respond to a minimal amount of ligand alpha-galactosylceramide (alphaGalCer) through CD1d-dependent autoreactive responses that require endosomal processing and CD1d trafficking. The ability of potentiation of NKT cells was DC specific and did not depend on costimulatory signals and IL-12 production by DCs. However, DCs that failed to synthesize a major endogenous lipid Ag isoglobotrihexosylceramide were unable to potentiate NKT cells for efficient activation. Further analysis showed that differences in the level and pattern of endogenous lipid Ag presentation differentiate DCs and B cells for effective potentiation and subsequent activation of iNKT cells in the presence of an exogenous Ag. Thus, CD1d-dependent potentiation by DCs may be crucial for iNKT cell-mediated immunity against infectious agents.
authors.affiliation: Julia McFarlane Diabetes Research Centre, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada.
authors.forename: Lu
authors.initials: L
authors.lastname: Cheng
authors.forename: Aito
authors.initials: A
authors.lastname: Ueno
authors.forename: Suzanne
authors.initials: S
authors.lastname: Cho
authors.forename: Jin S
authors.initials: JS
authors.lastname: Im
authors.forename: Susanne
authors.initials: S
authors.lastname: Golby
authors.forename: Sheng
authors.initials: S
authors.lastname: Hou
authors.forename: Steven A
authors.initials: SA
authors.lastname: Porcelli
authors.forename: Yang
authors.initials: Y
authors.lastname: Yang
mesh_terms: D000818:Animals; D017951:Antigen Presentation / Q000276:immunology; D000941:Antigens / Q000276:immunology; D018949:Antigens, CD1 / Q000276:immunology; D055610:Antigens, CD1d; D001402:B-Lymphocytes / Q000276:immunology; D003713:Dendritic Cells / Q000276:immunology*; D011992:Endosomes / Q000276:immunology; D005699:Galactosylceramides / Q000276:immunology*; D005915:Globosides / Q000276:immunology*; D007111:Immunity, Cellular; D018664:Interleukin-12 / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology*; D008213:Lymphocyte Activation / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D016513:Mice, SCID; D021381:Protein Transport / Q000276:immunology; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology*; D017634:Self Tolerance / Q000276:immunology; D015398:Signal Transduction / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D014281:Trihexosylceramides / Q000276:immunology*
chemical_list: D000941:Antigens; D018949:Antigens, CD1; D055610:Antigens, CD1d; D005699:Galactosylceramides; D005915:Globosides; D016693:Receptors, Antigen, T-Cell, alpha-beta; D014281:Trihexosylceramides; C493154:alpha-galactosylceramide; C514781:isoglobotrihexosylceramide; D018664:Interleukin-12